Evidence map›Paper›PMID 40442102›Full record

ArticleACS applied bio materials2025

Development of Theranostic

Hsin-Hua Hsieh, Shih-Po Su, Yang-Hsiang Chan, Huihua Kenny Chiang, Yi-Jang Lee, Chun-Yi Wu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS applied bio materials, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Linking In Vivo Imaging to Therapeutic Outcome withInternational journal of molecular sciences · 2026
    Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Hsin-Hua HsiehDepartment of Biomedical Imaging and Radiological Sciences, National Yang Ming Chiao Tung University, Taipei 112, Taiwan.
Shih-Po SuDepartment of Biomedical Engineering, National Yang Ming Chiao Tung University, Taipei 112, Taiwan.
Yang-Hsiang ChanDepartment of Applied Chemistry, National Yang Ming Chiao Tung University, Hsinchu 300, Taiwan.ORCID 0000-0001-6496-2362
Huihua Kenny ChiangDepartment of Biomedical Engineering, National Yang Ming Chiao Tung University, Taipei 112, Taiwan.
Yi-Jang LeeDepartment of Biomedical Imaging and Radiological Sciences, National Yang Ming Chiao Tung University, Taipei 112, Taiwan.ORCID 0000-0002-0340-7557
Chun-Yi WuDepartment of Biomedical Imaging and Radiological Sciences, National Yang Ming Chiao Tung University, Taipei 112, Taiwan.ORCID 0000-0002-8217-1692

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study presents the development of

Indexed as

Antineoplastic AgentsBiocompatible MaterialsHead and Neck NeoplasmsLutetiumNanoparticlesPolymersRadioisotopesTheranostic NanomedicineAnimalsCell ProliferationCell SurvivalDrug Screening Assays, AntitumorHumansMaterials TestingMiceParticle SizeAntineoplastic AgentsBiocompatible MaterialsLutetiumLutetium-177PolymersRadioisotopes177Lu-labeled polymeric nanoparticles (177Lu-PNPs)head and neck cancerNIR-II imagingphotothermal therapyradiopharmaceutical therapy

Identifiers

PMID40442102
PMCPMC12175126

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.